These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29709869)

  • 1. A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.
    Gardiner BJ; Thorpe CM; Pinkham NV; McDermott LA; Walk ST; Snydman DR
    Anaerobe; 2018 Jun; 51():68-72. PubMed ID: 29709869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection.
    Barfuss S; Knackstedt ED; Jensen K; Molina K; Lal A
    Transpl Infect Dis; 2018 Dec; 20(6):e12983. PubMed ID: 30155958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.
    Tariq R; Pardi DS; Tosh PK; Walker RC; Razonable RR; Khanna S
    Clin Infect Dis; 2017 Oct; 65(10):1745-1747. PubMed ID: 29020210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the cause of recurrent Clostridium difficile infection using whole genome sequencing.
    Sim JH; Truong C; Minot SS; Greenfield N; Budvytiene I; Lohith A; Anikst V; Pourmand N; Banaei N
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):11-16. PubMed ID: 27771207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
    Khoruts A
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
    Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
    Goldenberg SD
    J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Leung V; Vincent C; Edens TJ; Miller M; Manges AR
    Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
    Jalanka J; Hillamaa A; Satokari R; Mattila E; Anttila VJ; Arkkila P
    Aliment Pharmacol Ther; 2018 Feb; 47(3):371-379. PubMed ID: 29226561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.
    Lagier JC; Delord M; Million M; Parola P; Stein A; Brouqui P; Raoult D
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1597-601. PubMed ID: 25947205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.
    Shaughnessy MK; Bobr A; Kuskowski MA; Johnston BD; Sadowsky MJ; Khoruts A; Johnson JR
    Appl Environ Microbiol; 2016 May; 82(9):2686-2692. PubMed ID: 26921425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
    Gómez S; Chaves F; Orellana MA
    Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].
    Haemers I; Delvallée M
    Rev Med Brux; 2016; 37(3):174-177. PubMed ID: 28525191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologic factors affecting Clostridium difficile recurrence.
    Chilton CH; Pickering DS; Freeman J
    Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
    Di Bella S; Gouliouris T; Petrosillo N
    J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
    Diamond C; McNeilly T
    Ulster Med J; 2017 May; 86(2):108-110. PubMed ID: 29535482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.